Searchable abstracts of presentations at key conferences in endocrinology

ea0021p355 | Steroids | SFEBES2009

Salivary annexin 1 has a diurnal rhythm but does not share an awakening response with cortisol at 30 min

Renshaw Derek , Korbonits Marta , Flower Rod , Perretti Mauro , Fowkes Robert

Several hormones, including cortisol, have a circadian rhythm in plasma and saliva. Salivary cortisol is now extensively used for screening and following patients with various conditions where the regulation of hypothalamo-pituitary–adrenal axis is abnormal, for example in major depression where salivary cortisol levels show a disruption or loss of the circadian rhythm.Annexin 1 is a glucocorticoid-induced protein, which is responsible for mediating...

ea0019p123 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Expression of ghrelin O-acyltransferase (GOAT), the newly-identified ghrelin acylation enzyme, in various human tissues

Lim CT , Kola B , Igreja S , Grossman AB , Korbonits M

Ghrelin is a circulating growth hormone-releasing and appetite-inducing brain–gut peptide. It needs to be acylated on its serine-3 with octanoate for its endocrine actions. The acyl-transferase that catalyses ghrelin octanoylation has been recently identified and named GOAT (ghrelin O-acyltransferase), which is coded by the MBOAT4 gene. This study aimed to investigate GOAT expression in human. The distribution of GOAT mRNA expression was studied in various human ti...

ea0012oc17 | Pituitary, ovary and steroids | SFE2006

Prolactinomas: all in the family?

Razvi S , Ashwell S , Korbonits M , Quinton R Quinton R

ObjectiveTo report and discuss a kindred with pathological hyperprolactinaemia.Case 1 (Proband)A 39-year old man presented in June 2003 with 3-years of erectile dysfunction (ED) and was found to have hyperprolactinaemic hypogonadotrophic hypogonadism: LH 1.0 & FSH 1.5 U/L, Testosterone 5.8 nmol/L, PRL 4154 mU/L. Pituitary function was otherwise normal. MRI demonstrated an intrasellar macroadenoma. Cabergo...

ea0009oc23 | Oral Communication 3: Neuroendocrinology | BES2005

Ghrelin and cannabinoid interactions on food intake

Korbonits M , Tucci S , Rogers E , Kirkham T

The hypothalamus plays a key role in the control of appetite and energy balance. The endogenous cannabinoids are widely distributed throughout the brain, including the hypothalamus, together with specific cannabinoid-1 (CB-1) receptors. Endogenous and exogenous cannabinoids induce hyperphagia, whereas the selective CB-1 receptor antagonist, SR 141716 (rimonabant), inhibits feeding and CB-1 knockout animals are leaner and eat less after an overnight fast. Ghrelin, the recently ...

ea0009p90 | Endocrine tumours and neoplasia | BES2005

The effect of somatostatin analogues on p27 and on mitogen-activated protein kinase (MAPK) in different human pituitary tumour cells

Hubina E , Czirjak S , Goth M , Grossman A , Korbonits M

Somatostatin and its analogues negatively regulate the growth of multiple epithelial cell types. This anti-proliferative effect occurs through multiple mechanisms, one of which is cell cycle arrest at the G0/G1 phase. p27, a cyclin-dependent kinase inhibitor, has a negative influence on cell cycle progression, and there are recent data suggesting that somatostatin increases p27 levels. We have previously shown that pituitary adenoma cells contain less p27 protein than normal p...

ea0009p100 | Endocrine tumours and neoplasia | BES2005

BRAF mRNA is over-expressed in pituitary adenomas, but the oncogenic BRAF mutation V5999E is not a frequent finding

Pedder-Smith S , Emery M , Musat M , Korbonits M , Grossman A

Sporadic pituitary tumours are generally benign tumours in which the none of the oncogenes or tumour suppressor genes classically mutated in other cancers are commonly mutated, nor are there frequent changes in genes associated with genetic endocrine neoplasia syndromes. Such tumours are associated with excessive but not completely unregulated proliferation, implicating a possible abnormality in a cell signalling pathway in their pathogenesis. Recently, the serine/threonine ki...

ea0009p184 | Clinical | BES2005

Refeeding Blaine: studies following a 44 day fast

Korbonits M , Blaine D , Elia M , Powell-Tuck J

The opportunity to study the effects of prolonged fasting is rare. In this study we recorded anthropometric, biochemical and endocrine changes during the refeeding period following a 44 day fast, and compared them with results from 16 age-, sex- and body mass index (BMI)-matched controls.The index subject took only water to drink during the fast. He lost 24.5kg changing his BMI from 29 to 21.6. He underwent careful slow refeeding for the first 4 days usi...

ea0007p79 | Endocrine tumours and neoplasia | BES2004

Is there an ultra-short loop feedback of ACTH on itself?

Sharma M , Nanzer A , Morris D , Adams E , Korbonits M , Grossman A

It has been postulated that ACTH might modulate its own secretion by a negative feedback loop and we have recently found that the ACTH receptor (MC2R) is present in both normal and tumorous human corticotrophs. In this study we investigated the expression of the ACTH receptor in mouse and rat pituitary tissue as well as mouse pituitary tumour (AtT20) cells and studied the effect of Synacthen (ACTH [1-24]) on ACTH secretion, cAMP release and cell proliferation in AtT20 cells. M...

ea0003p107 | Diabetes & Metabolism | BES2002

Single nucleotide polymorphisms in the ghrelin gene in tall obese children

Gueorguiev M , O'Grady E , Grossman A , Froguel P , Korbonits M

In addition to its original growth hormone-releasing function,ghrelin has been shown to exert a variety of effects on metabolism,specifically in terms of the regulation of body habitus and fat. Itincrease food intake and body weight, and regulates energyhomeostasis: it also increases glucose levels, reduces insulinsecretion and regulates downstream insulin signa...

ea0094p51 | Innovation in Teaching | SFEBES2023

Genomic notes for clinicians – A genomic testing resource for endocrinologists

Gohil Shailesh , Korbonits Marta , Casey Ruth , Newey Paul , Levy Miles

Introduction: Genomic testing is expected to become a part of mainstream testing in the not-too-distant future, with clinicians ordering genetics tests in the same way routine endocrine tests are requested today. Knowledge on how and what test to request needs to be gathered by a wide range of physicians. To support this, the Genomics Education Programme of NHS England is developing a resource for all endocrinologists to use in clinic as part it’s Genomic...